Trillium Asset Management LLC boosted its stake in Shire PLC (NASDAQ:SHPG) by 153.8% during the second quarter, Holdings Channel reports. The firm owned 48,001 shares of the biopharmaceutical company’s stock after buying an additional 29,087 shares during the period. Trillium Asset Management LLC’s holdings in Shire PLC were worth $7,933,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Whittier Trust Co. raised its position in Shire PLC by 19.1% in the first quarter. Whittier Trust Co. now owns 573 shares of the biopharmaceutical company’s stock valued at $100,000 after buying an additional 92 shares during the period. Pinnacle Bank purchased a new position in Shire PLC during the first quarter valued at approximately $101,000. Hartford Financial Management Inc. raised its position in Shire PLC by 5.4% in the second quarter. Hartford Financial Management Inc. now owns 621 shares of the biopharmaceutical company’s stock valued at $102,000 after buying an additional 32 shares during the period. Thompson Davis & CO. Inc. raised its position in Shire PLC by 3.1% in the first quarter. Thompson Davis & CO. Inc. now owns 640 shares of the biopharmaceutical company’s stock valued at $112,000 after buying an additional 19 shares during the period. Finally, North Star Investment Management Corp. raised its position in Shire PLC by 8.5% in the first quarter. North Star Investment Management Corp. now owns 756 shares of the biopharmaceutical company’s stock valued at $132,000 after buying an additional 59 shares during the period. Hedge funds and other institutional investors own 20.22% of the company’s stock.

Shares of Shire PLC (NASDAQ SHPG) opened at 147.77 on Tuesday. Shire PLC has a 1-year low of $147.28 and a 1-year high of $209.22.

Shire PLC (NASDAQ:SHPG) last announced its earnings results on Thursday, August 3rd. The biopharmaceutical company reported $3.73 EPS for the quarter, beating analysts’ consensus estimates of $3.53 by $0.20. The business had revenue of $3.75 billion for the quarter. Shire PLC had a net margin of 6.33% and a return on equity of 3.18%. The business’s revenue was up 54.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.38 earnings per share. Equities research analysts predict that Shire PLC will post $14.95 EPS for the current year.

The firm also recently announced a semiannual dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 8th will be issued a $0.1527 dividend. The ex-dividend date of this dividend is Thursday, September 7th. This represents a dividend yield of 0.21%. Shire PLC’s payout ratio is 40.63%.

TRADEMARK VIOLATION WARNING: This piece was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.watchlistnews.com/shire-plc-shpg-stake-raised-by-trillium-asset-management-llc/1490293.html.

SHPG has been the subject of several recent analyst reports. Stifel Nicolaus reduced their price objective on shares of Shire PLC from $250.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, June 9th. Jefferies Group LLC reiterated a “buy” rating and set a $216.00 price objective (down previously from $239.00) on shares of Shire PLC in a research note on Friday, June 9th. Royal Bank Of Canada set a $221.00 price objective on shares of Shire PLC and gave the stock a “buy” rating in a research note on Thursday, May 18th. Cantor Fitzgerald set a $222.00 price objective on shares of Shire PLC and gave the stock a “buy” rating in a research note on Saturday, July 1st. Finally, ValuEngine upgraded shares of Shire PLC from a “hold” rating to a “buy” rating in a research note on Thursday, July 6th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have given a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $222.27.

Shire PLC Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).

Institutional Ownership by Quarter for Shire PLC (NASDAQ:SHPG)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.